Analgesics in Mexico - New Market Study Published

In December 2013, Casa Saba, the leading Mexican distributor of medicines, sold its distribution business to the North American companies Pharma Equity Global and World Global Equity. This was the first of many moves that Casa Saba made after declaring bankruptcy. As Casa Saba was previously the largest Mexican distributor of medicines, this sale negatively affected many Rx and OTC categories, and analgesics was no exception.

Competitive Landscape

Analgesics in Mexico is highly fragmented, with only three companies holding more than a 10% value share in 2015. The leading company in 2015 was Bayer de México, accounting for a 24% value share, closely followed by Bristol-Myers Squibb de México, which accounted for a 19% value share. The third company was Johnson & Johnson de México, which held a 10% value share. Bayer benefits from being in the country for decades, maintaining its position with the still-popular slogan "if it’s Bayer it’s good." Bayer owns the Flanax and Aspirina brands, which almost represent their categories, as their brand names mean almost any other naproxen (in the case of Flanax) or aspirin (in the case of aspirin). Bristol-Myers Squibb owns the leading acetaminophen brand for babies and children, Tempra, whilst Johnson & Johnson has a strong presence with Motrin (paediatric ibuprofen) and Tylenol (acetaminophen), which is preferred by some consumers thanks to the "no stomach irritating" benefit compared with other analgesics for adults.

Full Report Details at
- http://www.fastmr.com/prod/1110481_analgesics_mexico.aspx?afid=301

Industry Prospects

Over the forecast period analgesics is expected to see a value CAGR of 2% at constant 2015 prices, to reach Mx$4.8 billion in 2020. Although analgesics is a mature category, the lifestyles of the Mexican population will maintain stable growth for these products, to relieve the pain derived from stress, long periods in traffic and long working hours.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Mexico with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Mexico, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Mexico market research report includes:

* Analysis of key supply-side and demand trends
* Detailed segmentation of international and local products
* Historic volumes and values, company and brand market shares
* Five year forecasts of market trends and market growth
* Robust and transparent market research methodology, conducted in-country



About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Analgesics in Japan
- Analgesics in Denmark
- Analgesics in the United Kingdom
- Analgesics in Russia
- Analgesics in Sweden